return to corporate website
Menu
Return to
www.noxopharm.com
Home
About Us
About Noxopharm
Management Team
Board of Directors
Scientific Advisors
Corporate Governance
Company Constitution
Sustainability
Noxopharm History
Research and Clinical Programs
Research and Clinical Programs
About Pharmorage
Investor Centre
Share Price
ASX Announcements
Why Invest in Noxopharm
Presentations & Interviews
Annual Reports
Financial Reports
Analyst Reports
Investor Fact Sheet
Investor FAQs
Upcoming Events
Privacy Policy
Share Registry Information
Contact Us
Contact Us
Partnering
Working at Noxopharm
Newsletter Email Alerts
ASX Announcements Email Alerts
Investor Centre
Home
>
Investor Centre
>
ASX Announcements
Share Price
ASX Announcements
Why Invest in Noxopharm
Presentations & Interviews
Annual Reports
Financial Reports
Analyst Reports
Investor Fact Sheet
Investor FAQs
Upcoming Events
Privacy Policy
Share Registry Information
ASX Announcements
Filter by Year:
2022
2021
2020
2019
2018
2017
2016
21-Feb-2022
Appendix 4D and Half Year 2022 Financial Report
1-Feb-2022
Initial Director's Interest Notice - GM
27-Jan-2022
December 2021 Quarterly Activities Report and Appendix 4C
10-Jan-2022
Noxopharm Presents at H.C. Wainwright BioConnect Conference
7-Jan-2022
Noxopharm Receives A$5.865M R & D Tax Rebate
5-Jan-2022
Noxopharm Announces Leadership Transition
Previous
1
2
